Aurigene

Kaushik Gopal Bhattacharaya, Head - Territory Sales Support (Global), Syngene International highlights how outbound leads in the…

AI and ML-assisted platform reduced cycle time from chemical design to synthesis and testing by 35 per cent

The Indus-III study met its primary endpoint of PASI-75 response at 12 weeks at the 400 mg BID dose, when compared to placebo